This webinar on June 5th reviewed effective strategies for cancer immunotherapy administration by providing a glance at IO access across the United States, the United Kingdom, and Nigeria. It featured presentations on different models of access, the challenges related to increasing access to...
AI is being investigated for real-time monitoring of patients receiving immunotherapy for immune-related adverse events (irAE). Earlier and more accurate detection of toxicities can vastly improve patient outcomes. The first webinar in our series on May 2nd educated participants on the current...
SITC thanks Policy Committee chair Dr. Ryan Sullivan and many other SITC members for assisting with this year's hill visits. SITC members held over 25 Congressional meetings, including in-person meetings with Dr. Sullivan, on a host of important issues affecting cancer immunotherapy research. ...
The Global Access and Impact Committee, in collaboration with the Diversity, Equity, and Inclusion Committee, is pleased to launch SITC's first educational program crafted specifically for international audiences, titled " Increasing Access to IO: A Global Webinar Series ". This series will...
SITC has provided full comments on a recently released FDA Draft Guidance: "Potency Assurance for Cellular and Gene Therapy Products". Please find the letter in its entirety HERE . #Policy
SITC has provided meeting coverage of the March 15th ODAC meeting. The coverage includes an overview of the discussion, including representation of the different stakeholder perspectives on each issue, as well as a summary of all recommendations from ODAC. The coverage can be found in its...
SITC has provided a letter to ODAC providing insight into the implications of control arm crossover use within clinical trials. The letter also provides support for the use of Progression Free Survival as a viable surrogate endpoint within clinical trials. Please find the letter in its entirety ...
Thank you to Dr. Ahmad Tarhini from Moffitt Cancer Center and Research Institute for partici pating in SITC’s 2024 Capitol Hill Visits. Dr. Tarhini met with Senator Rubio’s and Representative Castor’s offices to advocate for inclusion of SITC’s FY25 appropriations...
Thank you to Dr. Nathan Singh from Washington University School of Medicine for participating in SITC’s 2024 Capitol Hill Visits. Dr. Singh met with Senator Hawley ’s and Representative B ush ’s offices to advocate for inclusion of SITC’s FY25 appropriations language aimed at...
Thank you to Dr. Cecilia Yeung from Fred Hutchinson Cancer Research Center for participating in SITC’s 2024 Capitol Hill Visits. Dr. Yeung met with Senator Murray’s, Senator Cantwell’ s and Representative Jayapal ’s offices to advocate for inclusion of SITC’s FY25 appropriations...
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us